Search research articles
Contact Us
Filters
Showing results (111-120 of 172) with videos related to
Page
of 18
Sort By:
British Journal of Clinical Pharmacology
|
December 1, 1991
Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine
M Pirmohamed, A Graham, P Roberts, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 29, 2000
The burden of alcohol misuse on an inner-city general hospital
M Pirmohamed, C Brown, L Owens, et al.
Postgraduate Medical Journal
|
August 1, 1989
Use of adrenal arterial embolization in severe ACTH-dependent Cushing's syndrome
S B Blunt, M Pirmohamed, V K Chatterjee, et al.
Clinical Pharmacology and Therapeutics
|
March 2, 2012
Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing
M A Martin, T E Klein, B J Dong, et al.
Toxicology
|
December 18, 1996
Characterisation of the toxic metabolite(s) of naphthalene
A S Wilson, C D Davis, D P Williams, et al.
Pharmacogenetics
|
April 20, 1999
The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation
H J Gill, J F Tjia, N R Kitteringham, et al.
British Journal of Pharmacology
|
April 27, 1999
Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity
D J Naisbitt, S J Hough, H J Gill, et al.
Current Drug Metabolism
|
July 3, 2002
Are chemically reactive metabolites responsible for adverse reactions to drugs?
D P Williams, N R Kitteringham, D J Naisbitt, et al.
AIDS Research and Human Retroviruses
|
January 12, 2001
Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection
D J Naisbitt, F J Vilar, A C Stalford, et al.
Biochemical Pharmacology
|
November 2, 1993
An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes
M D Tingle, M Pirmohamed, E Templeton, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 172) with videos related to
Sort By:
Page
of 18
British Journal of Clinical Pharmacology
|
December 1, 1991
Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine
M Pirmohamed, A Graham, P Roberts, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 29, 2000
The burden of alcohol misuse on an inner-city general hospital
M Pirmohamed, C Brown, L Owens, et al.
Postgraduate Medical Journal
|
August 1, 1989
Use of adrenal arterial embolization in severe ACTH-dependent Cushing's syndrome
S B Blunt, M Pirmohamed, V K Chatterjee, et al.
Clinical Pharmacology and Therapeutics
|
March 2, 2012
Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing
M A Martin, T E Klein, B J Dong, et al.
Toxicology
|
December 18, 1996
Characterisation of the toxic metabolite(s) of naphthalene
A S Wilson, C D Davis, D P Williams, et al.
Pharmacogenetics
|
April 20, 1999
The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation
H J Gill, J F Tjia, N R Kitteringham, et al.
British Journal of Pharmacology
|
April 27, 1999
Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity
D J Naisbitt, S J Hough, H J Gill, et al.
Current Drug Metabolism
|
July 3, 2002
Are chemically reactive metabolites responsible for adverse reactions to drugs?
D P Williams, N R Kitteringham, D J Naisbitt, et al.
AIDS Research and Human Retroviruses
|
January 12, 2001
Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection
D J Naisbitt, F J Vilar, A C Stalford, et al.
Biochemical Pharmacology
|
November 2, 1993
An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes
M D Tingle, M Pirmohamed, E Templeton, et al.
Page
of 18